Two new medications offer novel mechanisms of action to treat patients with schizophrenia who don't respond to other antipsychotic drugs.
Why we need new schizophrenia treatments How we know that TAAR1 plays a role in schizophrenia How targeting TAAR1 treats schizophrenia
Two new medications offer novel mechanisms of action to treat patients with schizophrenia who don't respond to other antipsychotic drugs.
by A Whitten 2024Current drugs for treating schizophrenia all focus on targeting the Stay connected with all of the latest from Drug Discovery News.
Vraylar is a relatively new antipsychotic drug, that has been approved for treating schizophrenia, and as an add-on medication in treating episodic bipolar
Ireland's Alkermes has submitted a new drug application (NDA) to the Aristada (aripiprazole lauroxil) to treat schizophrenia.
Based on their analyses of schizophrenia drug trials submitted by drug new trials of drugs to treat schizophrenia. Shorter-duration trials
Within the past year, the FDA approved a New Drug Application for aripiprazole, a bi-monthly injection, that treats schizophrenia and bipolar
These are drugs used to treat schizophrenia, a mental illness that has been portrayed often in the news and other media, though not always accurately.
Comments